Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    weill | Open Studies | "Digestive System Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Endoscopic Resection Multicenter Registry
Conditions: Gastrointestinal Neoplasms;   Gastrointestinal Disease;   Gastric Cancer;   Gastric Neoplasm;   Gastric Polyp;   Esophageal Neoplasms;   Duodenal Neoplasms;   Duodenal Polyp;   Stomach Neoplasm;   Stomach Polyp;   Neoplasms;   Colon Polyp;   Colon Neoplasm
Intervention: Procedure: Endoscopic Resection
2 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention: Procedure: Interventional Endoscopy
3 Not yet recruiting Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Condition: Esophageal Adenocarcinoma
Interventions: Drug: Pembrolizumab;   Drug: Taxol;   Drug: Carboplatin
4 Recruiting 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer;   Head and Neck Cancer;   Breast Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Ovarian Cancer;   Esophageal Cancer;   Gliomas
Intervention: Drug: 177Lu-J591
5 Recruiting T-EUS for Gastrointestinal Disorders: A Multicenter Registry
Conditions: Cholangiocarcinoma;   Pancreatic Cancer;   Bile Duct Cancer;   Biliary Stricture;   Biliary Obstruction;   Stent Obstruction;   Proximal Duct Stricture;   Distal Duct Stricture;   Ampullary Cancer;   Biliary Sphincter Stenosis;   Impacted Stones;   Chronic Pancreatitis;   Peri-ampullary Diverticula;   Altered Anatomy
Intervention: Procedure: EUS guided ERCP
6 Recruiting Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
Conditions: Cholangiocarcinoma;   Pancreatic Cancer;   Bile Duct Cancer;   Biliary Stricture;   Bile Duct Obstruction
Intervention: Device: Radio Frequency ablation Probe
7 Recruiting EUS BD vs ERCP TP for Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Adenocarcinoma;   Biliary Tract Neoplasms;   Biliary Duct Obstruction;   Unresectable Pancreatic Cancer;   Periampullary Cancer;   Periampullary Carcinoma Non-Resectable
Interventions: Procedure: Endoscopic Ultrasound Guided Biliary Drainage;   Procedure: ERCP
8 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
9 Recruiting RFA RCT for Pancreatic or Bile Duct Cancer
Conditions: Unresectable Pancreatic Cancer;   Cholangiocarcinoma Non-resectable
Interventions: Procedure: Radiofrequency Ablation using EndoHPB Probe;   Procedure: Stenting only
10 Recruiting FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Gastric Adenocarcinoma;   Gastric Cancer
Interventions: Procedure: FDG-PET;   Procedure: surgery;   Drug: 5-FU;   Drug: capecitabine;   Drug: docetaxel;   Drug: Irinotecan;   Radiation: 3D-CRT;   Radiation: IMRT
11 Recruiting Perioperative Chemo and Pembrolizumab in Gastric Cancer
Conditions: Gastric Cancer;   Adenocarcinoma of the Gastroesophageal Junction
Interventions: Drug: Pembrolizumab;   Drug: Standard of care chemotherapy regimen
12 Recruiting Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Conditions: Pancreatic Cancer;   Benign Pancreatic Disease
Intervention:
13 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
14 Recruiting Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Condition: Lynch Syndrome
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Naproxen;   Other: Placebo
15 Recruiting Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Gastric Cancer
Intervention: Drug: FPA144
16 Recruiting A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Conditions: Rectal Cancer;   Rectosigmoid Cancer
Interventions: Device: PINPOINT;   Device: SPY Elite
17 Recruiting A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Conditions: Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Ramucirumab;   Drug: Paclitaxel
18 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
19 Recruiting PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX (chemotherapy);   Other: 5 FUCMT (chemoradiation);   Procedure: surgery;   Procedure: magnetic resonance imaging or endorectal ultrasound
20 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Carcinoma Breast Stage IV;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Urinary Bladder Neoplasms;   Cervical Cancer;   Endometrial Cancer;   Follicular Thyroid Cancer;   Glioblastoma Multiforme
Intervention: Drug: IMMU-132

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.